VaxGen Responds To Congressman Mike Rogers Call For Investigation Into Anthrax Vaccine Contract
Realtime Traders
(RTTNews) - Wednesday, VaxGen, Inc. (VXGN.PK) stated that it's President and Chief Executive Lance K. Gordon released a statement in response to the proposed investigation into the company's anthrax vaccine contract by Congressman Mike Rogers.
The President revealed that he was surprised by the call for an investigation into the Project BioShield anthrax vaccine contract as he feels that the contract bagged by the company from the Department of Health and Human Service - HHS was a resultant of an open, competitive and fair solicitation, which was extensive and also were in line with all applicable laws, rules and regulations.
Further, the President stated that the company won the deal as it met the demands of the previously bagged NIAID contracts and also that its bid was chosen by HHS based upon technological, scientific and cost grounds.
(RTTNews) - Wednesday, VaxGen, Inc. (VXGN.PK) stated that it's President and Chief Executive Lance K. Gordon released a statement in response to the proposed investigation into the company's anthrax vaccine contract by Congressman Mike Rogers.
The President revealed that he was surprised by the call for an investigation into the Project BioShield anthrax vaccine contract as he feels that the contract bagged by the company from the Department of Health and Human Service - HHS was a resultant of an open, competitive and fair solicitation, which was extensive and also were in line with all applicable laws, rules and regulations.
Further, the President stated that the company won the deal as it met the demands of the previously bagged NIAID contracts and also that its bid was chosen by HHS based upon technological, scientific and cost grounds.
